Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Common-Size Balance Sheet: Assets

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Medtronic PLC, common-size consolidated balance sheet: assets

Microsoft Excel
Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020 Apr 26, 2019
Cash and cash equivalents
Investments
Accounts receivable, less allowances and credit losses
Inventories
Other current assets
Current assets
Property, plant, and equipment, net
Goodwill
Other intangible assets, net
Tax assets
Other assets
Noncurrent assets
Total assets

Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Medtronic PLC current assets as a percentage of total assets decreased from 2022 to 2023 but then slightly increased from 2023 to 2024.
Property, plant, and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Medtronic PLC property, plant, and equipment, net as a percentage of total assets increased from 2022 to 2023 and from 2023 to 2024.
Noncurrent assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Medtronic PLC noncurrent assets as a percentage of total assets increased from 2022 to 2023 but then slightly decreased from 2023 to 2024.